Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 6/20 | 0.56 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.54 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.54 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.54 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.53 |
| ▸ | PLK3 | Q9H4B4 | 1/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.50 |
| ▸ | HPGD | P15428 | 3/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | GLA | P06280 | 1/20 | 0.50 |
| ▸ | PGAM1 | P18669 | 1/20 | 0.50 |
| ▸ | CASP1 | P29466 | 1/20 | 0.50 |
| ▸ | CASP7 | P55210 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 3/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.49 |
| ▸ | NMUR2 | Q9GZQ4 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1255489 | 0.89 | CYP3A4 (0.57) | MAOAAKR1C3AKR1C2AKR1C1NTRK1 | |
| SCHEMBL676341 | 0.83 | PTGS2 (0.55) | MAOANTRK1PLK3KDM4ECYP3A4 | |
| SCHEMBL571524 | 0.80 | MAOA (0.59) | MAOAKDM4ECYP3A4HPGDHSD17B10 | |
| Daidzein SCHEMBL2308593 | 0.80 | KDM4E (0.64) | MAOAKDM4ECYP3A4HPGDHSD17B10 | |
| SCHEMBL2318320 | 0.79 | CA1 (0.65) | MAOANTRK1PLK3KDM4ECYP3A4 | |
| SCHEMBL31675811 | 0.78 | NMUR2 (0.71) | MAOAAKR1C3AKR1C2AKR1C1NTRK1 | |
| SCHEMBL290080 | 0.78 | NMUR2 (0.71) | MAOAAKR1C3AKR1C2AKR1C1NTRK1 | |
| SCHEMBL6980060 | 0.76 | PTGS2 (0.61) | NTRK1PLK3KDM4ECYP3A4HPGD | |
| SCHEMBL10655426 | 0.75 | MAPK14 (0.59) | MAOAKDM4ECYP3A4HPGDHSD17B10 | |
| SCHEMBL1180659 | 0.74 | KDM4E (0.62) | MAOAKDM4ECYP3A4HPGDHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-214020732-U | Preparation facilities of 4, 7 dihydroxy isoflavone | 四川新一美生物科技有限公司 | 2021-08-24 | — | — | CN | claimed |
| EP-2875359-A2 | COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING METABOLIC SYNDROME DISORDERS | Charles R Drew University of Medicine and Science (US) | 2015-05-27 | — | — | EP | claimed |
| WO-2013149258-A2 | COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING METABOLIC SYNDROME DISORDERS | Charles Drew University of Medicine and Science (US) | 2013-10-03 | — | — | WO | claimed |
| EP-1438424-B1 | ENZYME SUBSTRATES FOR DETECTING BETA-D-RIBOFURANOSIDASE ACTIVITY | BURTON MICHAEL (GB) | 2006-01-18 | — | — | EP | claimed |
| US-20040259181-A1 | detecting beta-D-ribofuranosidase activity using novel chromogenic beta-D-ribofuranoside substrates such as catechol-beta-D-ribofuranoside or 3',4'-dihydroxyflavone-4'-beta-D-dibofuranoside; kits | BURTON MICHAEL (GB) | 2004-12-23 | — | — | US | claimed |
| EP-1438424-A2 | ENZYME SUBSTRATES FOR DETECTING BETA-D-RIBOFURANOSIDASE ACTIVITY | Burton, Michael (GB) | 2004-07-21 | — | — | EP | claimed |
| WO-2003035897-A2 | ENZYME SUBSTRATES FOR DETECTING BETA-D-RIBOFURANOSIDASE ACTIVITY | BURTON MICHAEL (GB) | 2003-05-01 | — | — | WO | claimed |
| US-20250339399-A1 | SUPRAMOLECULAR SELF-ASSEMBLY SYSTEM | BEIJING CREATRON INSTITUTE OF PHARMACEUTICAL RES CO LTD (CN) | 2025-11-06 | — | — | US | disclosed |
| CN-117384144-A | Method for preparing coumarin derivative by photocatalysis three components and application thereof | 浙江工业大学 | 2024-01-12 | — | — | CN | disclosed |
| CN-117045731-A | Pharmaceutical composition for improving estrogen disorder related diseases | 哈尔滨医科大学 | 2023-11-14 | — | — | CN | disclosed |
| EP-4259316-A2 | POLYMERIC MEMBRANE | 3M Innovative Properties Company (US) | 2023-10-18 | — | — | EP | disclosed |
| WO-2022123428-A2 | POLYMERIC MEMBRANE | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2022-06-16 | — | — | WO | disclosed |
| US-20210330611-A1 | THERAPY FOR NEUROLOGICAL DISEASES/DISORDERS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2021-10-28 | — | — | US | disclosed |
| EP-1438424-A2 | ENZYME SUBSTRATES FOR DETECTING BETA-D-RIBOFURANOSIDASE ACTIVITY | Burton, Michael (GB) | 2004-07-21 | — | — | EP | disclosed |
| WO-2004009576-A3 | MANUFACTURE OF ISOFLAVONES | DSM IP ASSETS BV (NL) | 2004-05-13 | — | — | WO | disclosed |
| WO-2004009576-A2 | MANUFACTURE OF ISOFLAVONES | DSM IP ASSETS B.V. (NL) | 2004-01-29 | — | — | WO | disclosed |
| WO-2003103583-A2 | A METHOD FOR USING TETHERED BIS(POLYHYDROXYPHENYLS) AND O-ALKYL DERIVATIVES THEREOF IN TREATING INFLAMMATORY CONDITIONS OF THE CENTRAL NERVOUS SYSTEM | OKLAHOMA MEDICAL RESEARCH FOUNDATION (US) | 2003-12-18 | — | — | WO | disclosed |
| WO-2003035897-A2 | ENZYME SUBSTRATES FOR DETECTING BETA-D-RIBOFURANOSIDASE ACTIVITY | BURTON MICHAEL (GB) | 2003-05-01 | — | — | WO | disclosed |
| CN-1103231-C | Preparation of active material and Chinese medicine preparation for resisting diabetes and its complication | SHI HAICHAO (CN) | 2003-03-19 | — | — | CN | disclosed |
| CN-1256140-A | Preparation of active material and Chinese medicine preparation for resisting diabetes and its complication | SHI HAICHAO (CN) | 2000-06-14 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250339399-A1 | SUPRAMOLECULAR SELF-ASSEMBLY SYSTEM | S100A8, TP53, AQP1 | MAOA 4262/4885AKR1C3 3214/4885AKR1C2 3153/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.